Pacific Biosciences Of California reported $-37573000 in Operating Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Agilent A:US $ 336M 48M
Bruker BRKR:US $ 85.6M 3.5M
Danaher DHR:US $ 2005M 5M
Fluidigm FLDM:US -17268000 2.05M
General Electric GE:US $ -993M 1246M
Genmark Diagnostics GNMK:US $ -2.09M 0.82M
Illumina ILMN:US $ 187M 6M
Luminex LMNX:US $ 13.46M 2.96M
Myriad Genetics MYGN:US $ -20.8M 25.9M
Nanostring Technologies NSTG:US $ -25.64M 0.23M
Oxford Immunotec Global OXFD:US $ 0.28M 10.11M
Pacific Biosciences Of California PACB:US $ -37.57M 48.14M
Perkinelmer PKI:US $ 332.49M 135.29M
Quidel QDEL:US $ 23.31M 200.88M
Thermo Fisher Scientific TMO:US $ 2163M 886M
Waters WAT:US $ 196.42M 25.15M